← Back to Search

Decision Aid vs Genetic Counseling for Ovarian and Pancreatic Cancer

N/A

Recruiting

Led By Daniel C. Chung, MD

Research Sponsored by Massachusetts General Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years or older

Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma.

Must not have

Members of the following vulnerable populations: adults unable to consent, individuals who are not yet adults

Previous germline genetic testing

Timeline

Screening 3 weeks

Treatment Varies

Follow Up initial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare how effective an electronic decision aid tool is versus a traditional genetic counselor session for people with ovarian or pancreatic cancer.

Who is the study for?

This trial is for adults over 18 with ovarian or pancreatic cancer, being treated at Massachusetts General Hospital or Boston Medical Center. It's not open to those who can't consent, minors, have had genetic testing before, or have hereditary pancreatitis.

What is being tested?

The study compares an electronic decision aid tool and traditional genetic counseling sessions to see which is more effective for gene panel testing in patients with certain types of cancer.

What are the potential side effects?

Since this trial involves decision aids and counseling rather than drugs or medical procedures, there are no direct physical side effects. However, participants may experience emotional or psychological impacts.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I have been diagnosed with ovarian or pancreatic cancer.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am able to give consent and am an adult.

Select...

I have had genetic testing for inherited conditions.

Select...

I have a family history of pancreatitis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ initial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~initial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and initial recorded recommendation/referral for genetic testing until the date of sample collection, assessed up to 6 months for reporting.